Resources
New diagnostics
The diagnostic pipeline has expanded considerably in terms of the number of tests, products or methods in development (Table 6.1). These include molecular tests for the detection of TB disease and drug resistance, interferon-gamma release assays (IGRAs) for the detection of TB infection, biomarker-based assays for detection of TB infection and disease, computer-aided detection (CAD) for TB screening using digital chest radiography, and a new class of aerosol-capture technologies for detection of TB disease.
Table 6.1
An overview of progress in the development of TB diagnostics, August 2023
- High sensitive LAM, Abbott Rapid Diagnostics, USA
- iChroma TB LAM, Boditech, Republic of Korea
- Standard F TB LAM assay, SD Biosensor, Republic of Korea
- Salus FLOW TB Urine LAM Assay, Salus Discovery LLC, USA
- Biopromic TB LAM Assay, Biopromic AB, Sweden
- Auragent TB LAM test, Auragent Bioscience LLC, USA
- Immunview TB LAM Ag test, SSI Diagnostica, Denmark
- AIMLAM, LDE Biosciences, China
- TB Triage multiplex LFA, LUMC, The Netherlands & the TB Triage consortium
- mfloDx MDR-TB, EMPE Diagnostics, India